Stock A066700 THERAGEN ETEX CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Theragen Etex Co.,Ltd.

Equities

A066700

KR7066700006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 04/06/2024 am IST 		5-day change 1st Jan Change
3,890 KRW 0.00% Intraday chart for Theragen Etex Co.,Ltd. -0.38% -12.98%
2023 MedPacto, Inc. announced that it has received KRW 10.85806127 billion in funding from Theragen Etex Co.,Ltd. CI
2023 MedPacto, Inc. announced that it expects to receive KRW 11.95668467 billion in funding from Theragen Etex Co.,Ltd. CI

Business Summary

THERAGEN ETEX CO.LTD. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The Company operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.

Number of employees: 201

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
91.2 %
169,347 87.6 % 202,160 91.2 % +19.38%
Healthcare and Genome Analysis
9.4 %
24,032 12.4 % 20,905 9.4 % -13.01%
Discontinued Operations
-0.6 %
- - -1,340 -0.6 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
98.8 %
190,695 98.6 % 219,152 98.8 % +14.92%
Overseas
1.2 %
2,685 1.4 % 2,572 1.2 % -4.18%

Managers

Managers TitleAgeSince
Byeong-Hwan Ryu CEO
 Chief Executive Officer 65 -
Jin-Up Go CEO
 Chief Executive Officer 72 13/06/13
Tae-Soon Hwang BRD
 Director/Board Member 55 -
Jeong-Geun Lee BRD
 Director/Board Member 77 -
Sang-Hoi Park AUD
 Comptroller/Controller/Auditor 64 -

Members of the board

Members of the board TitleAgeSince
Jin-Up Go CEO
 Chief Executive Officer 72 13/06/13
Kun-Sik Choi BRD
 Director/Board Member 79 -
Byeong-Hwan Ryu CEO
 Chief Executive Officer 65 -
Jeong-Geun Lee BRD
 Director/Board Member 77 -
Byeong-Man Lee BRD
 Director/Board Member 66 -
Tae-Soon Hwang BRD
 Director/Board Member 55 -
Bum-Ho Choi BRD
 Director/Board Member 60 11/19/11

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,474,435 26,541,339 ( 81.73 %) 469,056 ( 1.444 %) 81.73 %

Shareholders

NameEquities%Valuation
YUHAN CORPORATION
7.708 %
2,503,128 7.708 % 7 M ₩
Seong-Jin Kim
3.261 %
1,059,025 3.261 % 3 M ₩
Kun-Sik Choi
3.029 %
983,552 3.029 % 3 M ₩
THERAGEN ETEX CO.,LTD.
1.444 %
469,056 1.444 % 1 M ₩
CJ CHEILJEDANG CORPORATION
1.121 %
364,000 1.121 % 1 M ₩
Jin-Up Go
0.6939 %
225,352 0.6939 % 648 942 ₩
Jae-hoon Koh
0.5245 %
170,338 0.5245 % 490 519 ₩
Young-won Kim
0.4307 %
139,860 0.4307 % 402 752 ₩
Seong-sook Lee
0.3607 %
117,141 0.3607 % 337 329 ₩
Sae-rom Kim
0.2547 %
82,708 0.2547 % 238 173 ₩

Holdings

NameEquities%Valuation
MEDPACTO, INC.
14.68%
 4,931,039 14.68% 34,607,560 $
THERAGEN ETEX CO.,LTD.
1.44%
 469,056 1.44% 1,350,731 $

Company contact information

THERAGEN ETEX Co., Ltd.

58 Sandan-ro 68beon-gil Danwon-gu

15438, Ansan-si

+

http://www.theragenetex.com
address Theragen Etex Co.,Ltd.(A066700)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
THERAGEN ETEX CO.,LTD. Stock Theragen Etex Co.,Ltd.
-12.98% 9.08Cr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+42.30% 75TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 60TCr
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.01% 36TCr
MERCK & CO., INC. Stock Merck & Co., Inc.
+17.95% 33TCr
ABBVIE INC. Stock AbbVie Inc.
+4.50% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.02% 24TCr
NOVARTIS AG Stock Novartis AG
+9.26% 21TCr
ROCHE HOLDING AG Stock Roche Holding AG
-4.21% 21TCr
PFIZER, INC. Stock Pfizer, Inc.
+2.85% 17TCr
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A066700 Stock
  4. Company Theragen Etex Co.,Ltd.